Free
Anesthesiology CME Program  |   October 2010
Instructions for Obtaining Anesthesiology Continuing Medical Education (CME) Credit
Article Information
Anesthesiology CME Program
Anesthesiology CME Program   |   October 2010
Instructions for Obtaining Anesthesiology Continuing Medical Education (CME) Credit
Anesthesiology 10 2010, Vol.113, A11. doi:10.1097/ALN.0b013e3181fac150
Anesthesiology 10 2010, Vol.113, A11. doi:10.1097/ALN.0b013e3181fac150
Anesthesiology's Journal CME is open to all readers. Members of the American Society of Anesthesiologists (ASA) enjoy a preferred rate for their subscription. However, Journal CME is not limited to ASA members or Journal subscribers. To take part in Journal CME, complete the following steps:
  1. For the article listed on the right, read the learning objectives and disclosure information.

  2. Read the article in the print or online edition.

  3. Register at and provide payment.

  4. Once online, complete the questions and other required information for the CME program, including the evaluation.

The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Anesthesiologists designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)  ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Purpose:  The focus of Anesthesiology Journal CME is to educate readers on current developments in the science and clinical practice of Anesthesiology.
Target Audience:  Anesthesiology Journal CME is designed for physicians involved with Anesthesiology education, clinical practice, and research.
Journal CME Planning Participants Disclosures
Editor-in-Chief:  James C. Eisenach, M.D., has no relevant financial relationships to disclose.
CME Editors:  Leslie C. Jameson, M.D., and Dan J. Kopacz, M.D., have no relevant financial relationships to disclose.
ASA Staff:  Employees involved in planning have no relevant financial relationships to disclose.
Claiming Credit
All tests and requests for credit must be submitted through the Anesthesiology CME website at . Participants should claim credit in 15-minute increments, for a maximum of 1 AMA PRA Category 1 Credit(s)  ™ per journal article.
Two payment options are available:
ASA Member Non-member
Annual Fee $60 $120
Per Issue $10 $20
Payment may be made using Visa or MasterCard.
Please direct any questions about Journal CME to:
Joyce Canselor
Education Coordinator, CME
(847) 268-9185
This Month's Anesthesiology Journal CME
Read the article by Wallace et al  . entitled “Association of the pattern of use of perioperative β-blockade and postoperative mortality” on page 794 and the accompanying editorial by Foëx and Sear entitled “Challenges of β blockade in surgical patients” on page 767 of this issue.
Learning Objective(s)
After completing this activity, the learner should be able to apply the current American College of Cardiology Foundation and the American Heart Association recommendation for perioperative β-blocker administration to patient care, recognize the risks of discontinuing β-blocker therapy in the perioperative period, and balance the risk/benefit of addingβ-blocker therapy to patients not receiving β-blockers prior to surgery.
Author(s) Disclosures
Authors:  Arthur W. Wallace, M.D., Ph.D., Selwyn Au, M.S., and Brian A. Cason, M.D., have no financial interest in or affiliation with any commercial supporter or providers of any commercial services discussed in this educational material.
Authors:  Pierre Foëx, M.D., D.Phil., F.R.C.A., F.A.N.Z.C.A., F.C.A.(S.A.), F.Med.Sci., is a consultant for Baxter Healthcare Corporation and was a UK investigator in the POISE study (but not involved in the writing of the paper), which was funded in part by AstraZeneca. John W. Sear, B.Sc., Ph.D., M.B.B.S., F.F.A.R.C.S., F.A.N.Z.C.A., is a consultant for Baxter Healthcare Corporation and was a UK investigator in the POISE study (but not involved in the writing of the paper), which was funded in part by AstraZeneca.
Expiration
Registration and submission of answers must be completed by October 31, 2013.